Instituto de Psiquiatria, Hospital das Clinicas.
J Psychopharmacol. 1996 Jan;10(4):313-6. doi: 10.1177/026988119601000410.
Dizziness is a frequent complaint during the initial worsening of panic patients treated with clomipramine. In order to investigate the relationship between dizziness and initial worsening mechanisms, otoneurological tests were administered to 32 consecutive patients with panic disorder, with or without agoraphobia, before treatment, 36 h after the first dose of 25 mg clomipramine and after treatment and full remission of the panic and agoraphobic symptoms. A pretreatment complaint of 'dizziness during panic attacks' but not the occurrence of otoneurological abnormalities, predicted the occurrence of clinical worsening at the start of treatment. A specific pattern of otoneurological abnormalities was not found, but only three patients had normal results in all three sessions. The inconsistent test results suggest that functional vestibular pathology is frequently associated with panic disorder.
头晕是接受氯米帕明治疗的惊恐障碍患者病情恶化初期的常见主诉。为了研究头晕与初始恶化机制之间的关系,在开始治疗前、首次服用 25 毫克氯米帕明 36 小时后以及惊恐和广场恐怖症状完全缓解后,对 32 例伴有或不伴有广场恐怖症的惊恐障碍患者进行了耳神经学检查。治疗前“惊恐发作时头晕”的主诉而非耳神经学异常的发生,预测了治疗开始时临床恶化的发生。并未发现特定的耳神经学异常模式,但仅有 3 例患者在所有 3 次检查中结果均正常。不一致的检查结果提示功能性前庭病理学常与惊恐障碍相关。